Award recordCONTRACT

GILEAD SCIENCES INC

PIID VA24814F0371· VHA· 248-NETWORK CONTRACT OFFICE 8 (36C248)· 6505 · DRUGS AND BIOLOGICALS· FY2014· $71,400 net obligations· UEI FPJMGUK1BYH8· CA

Description

IGF::OT::IGF PHARMACY PATIENT DELIVERY OF LETAIRIS

First action · last action
2014-01-23 · 2016-05-18
Transactions
3
First transaction's obligation
$102,096
Base + all options value (sum of deltas)
$71,400
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA797BP0416
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$102,096$0Base award · 2014-01-23 · this action $102,096 · running total $102,096Modification P00001 · 2015-08-07 · this action -$30,623 · running total $71,472Modification P00002 · 2016-05-18 · this action -$72 · running total $71,400
  • Base2014-01-23+$102,096= $102,096
  • Mod P000012015-08-07-$30,623= $71,472
  • Mod P000022016-05-18-$72= $71,400
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2014-01-23+$102,096$102,096IGF::OT::IGF PHARMACY PATIENT DELIVERY OF LETAIRIS
Mod P00001· OTHER ADMINISTRATIVE ACTION2015-08-07−$30,623$71,472IGF::OT::IGF PHARMACY PATIENT DELIVERY OF LETAIRIS
Mod P00002· CLOSE OUT2016-05-18−$72$71,400IGF::OT::IGF PHARMACY PATIENT DELIVERY OF LETAIRIS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI FPJMGUK1BYH8)

AwardOffice · PSC / listingNet obligationsFY
36C26125N0499261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$14,894FY2025
36C26025F0137260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$3,103FY2025
36C26025F0134260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$2,482FY2025
36C24524N0911245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$14,938FY2024
36C26024F0466260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$47,797FY2024
36C26024F0440260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$47,797FY2024

Other recipients under 6505 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24826F0207CSL BEHRING L.L.C.248-NETWORK CONTRACT OFFICE 8 (36C248)$183,903FY2026
36C24826P1108ASD SPECIALTY HEALTHCARE, LLC248-NETWORK CONTRACT OFFICE 8 (36C248)$54,600FY2026
36C24826P1090SIRTEX MEDICAL INC248-NETWORK CONTRACT OFFICE 8 (36C248)$45,825FY2026
36C24826N0511BIOMERIEUX INC248-NETWORK CONTRACT OFFICE 8 (36C248)$61,788FY2026
36C24826N0693MEDI-PHYSICS, INC.248-NETWORK CONTRACT OFFICE 8 (36C248)$111,150FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24814F0371_3600_VA797BP0416_3600 · retrieved 2026-09-27.